June 2026 Merck KGaA agreed to acquire Bio-Techne for approximately USD 11.3 billion, strengthening its life science portfolio in advanced biological research, gene expression analysis tools, cell and gene therapy, and precision diagnostics.
March 2026 Bio-Rad Laboratories launched the SEQuoia Express Stranded RNA Library Prep Kit, enabling faster and more efficient RNA sequencing library preparation for gene expression research and transcriptomics applications.
February 2026 QIAGEN expanded its QIAcuity digital PCR portfolio with new assays and workflow enhancements to improve highly sensitive gene expression analysis and biomarker research.
January 2026 Thermo Fisher Scientific introduced new transcriptomics and gene expression workflow solutions for next-generation sequencing and single-cell analysis, expanding its genomic research portfolio.